Nomura Asset Management Co. Ltd. Trims Stake in Nutrien Ltd. $NTR

Nomura Asset Management Co. Ltd. reduced its position in shares of Nutrien Ltd. (NYSE:NTRFree Report) by 14.8% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 135,560 shares of the company’s stock after selling 23,640 shares during the quarter. Nomura Asset Management Co. Ltd.’s holdings in Nutrien were worth $8,367,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. Montag A & Associates Inc. increased its holdings in Nutrien by 310.7% during the 4th quarter. Montag A & Associates Inc. now owns 423 shares of the company’s stock worth $26,000 after purchasing an additional 320 shares during the period. Eastern Bank increased its holdings in Nutrien by 133.0% during the 4th quarter. Eastern Bank now owns 699 shares of the company’s stock worth $43,000 after purchasing an additional 399 shares during the period. Harbour Investments Inc. increased its holdings in Nutrien by 97.2% during the 4th quarter. Harbour Investments Inc. now owns 704 shares of the company’s stock worth $43,000 after purchasing an additional 347 shares during the period. Geneos Wealth Management Inc. increased its holdings in Nutrien by 42.4% during the 2nd quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock worth $43,000 after purchasing an additional 219 shares during the period. Finally, Fulcrum Asset Management LLP purchased a new position in Nutrien during the 3rd quarter worth $46,000. 63.10% of the stock is currently owned by hedge funds and other institutional investors.

Nutrien Stock Up 0.7%

Shares of NYSE NTR opened at $68.97 on Thursday. The company has a current ratio of 1.24, a quick ratio of 0.59 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $33.11 billion, a PE ratio of 14.05, a price-to-earnings-growth ratio of 0.63 and a beta of 0.60. The stock’s fifty day simple moving average is $72.56 and its two-hundred day simple moving average is $68.76. Nutrien Ltd. has a 12-month low of $53.03 and a 12-month high of $85.36.

Nutrien (NYSE:NTRGet Free Report) last announced its earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.03. The business had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The business’s revenue for the quarter was up 18.5% on a year-over-year basis. During the same quarter last year, the firm earned $0.11 EPS. As a group, analysts expect that Nutrien Ltd. will post 5.45 EPS for the current fiscal year.

Nutrien Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 17th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 3.2%. The ex-dividend date of this dividend is Tuesday, June 30th. Nutrien’s dividend payout ratio (DPR) is 44.81%.

Analysts Set New Price Targets

NTR has been the topic of several research reports. Royal Bank Of Canada raised their price objective on Nutrien from $80.00 to $85.00 and gave the stock an “outperform” rating in a report on Tuesday, April 7th. Wall Street Zen downgraded Nutrien from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Wells Fargo & Company upgraded Nutrien from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $77.00 to $100.00 in a report on Friday, March 13th. Bank of America upgraded Nutrien from a “neutral” rating to a “buy” rating and set a $82.00 price objective on the stock in a report on Thursday, April 30th. Finally, BNP Paribas Exane cut Nutrien from an “outperform” rating to a “neutral” rating in a research report on Monday, February 23rd. Eleven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Nutrien currently has a consensus rating of “Moderate Buy” and a consensus target price of $82.75.

Read Our Latest Research Report on Nutrien

About Nutrien

(Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Featured Articles

Want to see what other hedge funds are holding NTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutrien Ltd. (NYSE:NTRFree Report).

Institutional Ownership by Quarter for Nutrien (NYSE:NTR)

Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.